• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酒精性肝炎患者临床应用预后评分的验证

Validation of prognostic scores for clinical use in patients with alcoholic hepatitis.

作者信息

Sandahl Thomas Damgaard, Jepsen Peter, Ott Peter, Vilstrup Hendrik

机构信息

Department of Medicine V (Hepatology and Gastroenterology), Aarhus University Hospital, Aarhus, Denmark.

出版信息

Scand J Gastroenterol. 2011 Sep;46(9):1127-32. doi: 10.3109/00365521.2011.587200. Epub 2011 May 18.

DOI:10.3109/00365521.2011.587200
PMID:21591871
Abstract

OBJECTIVE

In patients with alcoholic hepatitis, assessment of mortality risk is a key factor in the clinical management. Within the last decade, several prognostic scores have emerged. We aimed to evaluate and compare the predictive performances of the Glasgow alcoholic hepatitis score (GAHS); the model of end-stage liver disease (MELD); the MELD-Na; the Lille model; and the age, bilirubin, international normalized ratio, and creatinine (ABIC) score in a population-based unselected cohort of patients with alcoholic hepatitis.

MATERIAL AND METHODS

We applied the scoring systems to all 274 patients hospitalized and diagnosed with alcoholic hepatitis (1999-2008) in a Danish region of 1.1 million inhabitants. The ability of each score to predict mortality was evaluated using receiver operating characteristics curves, and the area under the receiver operating characteristics curves (AUROCs) were used to compare the scores.

RESULTS

The 28-day mortality was 16%, 84-day 27%, and 180-day 40%. The models had similar predictive properties with AUROC = 0.74-0.78 for 28-day mortality, 0.69-0.77 for 84-day mortality, and 0.65-0.75 for 180-day mortality. There were no statistically significant differences in the models' performances (p > 0.9). Re-scoring on day seven improved the AUROCs of the models (AUROC for 28-day, 0.75-0.83; 84-day, 0.75-0.79; and 180-day, 0.72-0.74).

CONCLUSIONS

The MELD, the MELD-Na, the GAHS, the Lille-model, and the ABIC scores each predicted the 28-, 84-, and 180-day mortality of our patients with alcoholic hepatitis and to the same degree, although not as well as in the original cohorts. Re-scoring on day seven improved the models' predictions.

摘要

目的

在酒精性肝炎患者中,评估死亡风险是临床管理的关键因素。在过去十年中,出现了几种预后评分系统。我们旨在评估并比较格拉斯哥酒精性肝炎评分(GAHS)、终末期肝病模型(MELD)、MELD-Na、里尔模型以及年龄、胆红素、国际标准化比值和肌酐(ABIC)评分在一个基于人群的未经过筛选的酒精性肝炎患者队列中的预测性能。

材料与方法

我们将这些评分系统应用于丹麦一个有110万居民的地区在1999年至2008年期间住院并被诊断为酒精性肝炎的所有274例患者。使用受试者工作特征曲线评估每个评分预测死亡的能力,并使用受试者工作特征曲线下面积(AUROC)来比较这些评分。

结果

28天死亡率为16%,84天为27%,180天为40%。这些模型具有相似的预测特性,28天死亡率的AUROC为0.74 - 0.78,84天死亡率的AUROC为0.69 - 0.77,180天死亡率的AUROC为0.65 - 0.75。各模型的性能无统计学显著差异(p > 0.9)。在第7天重新评分提高了模型的AUROC(28天的AUROC为0.75 - 0.83;84天的为0.75 - 0.79;180天的为0.72 - 0.74)。

结论

MELD、MELD-Na、GAHS、里尔模型和ABIC评分均能预测我们的酒精性肝炎患者的28天、84天和180天死亡率,且程度相同,尽管不如在原始队列中预测得好。在第7天重新评分改善了模型的预测效果。

相似文献

1
Validation of prognostic scores for clinical use in patients with alcoholic hepatitis.酒精性肝炎患者临床应用预后评分的验证
Scand J Gastroenterol. 2011 Sep;46(9):1127-32. doi: 10.3109/00365521.2011.587200. Epub 2011 May 18.
2
The amount of alcohol consumption negatively impacts short-term mortality in Mexican patients with alcoholic hepatitis.酒精摄入量的多少对患有酒精性肝炎的墨西哥患者的短期死亡率有负面影响。
Am J Gastroenterol. 2011 Aug;106(8):1472-80. doi: 10.1038/ajg.2011.141. Epub 2011 May 10.
3
Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis.预后评分在 STOPAH 试验中的应用:判别函数不再是酒精性肝炎的最佳评分系统。
J Hepatol. 2018 Mar;68(3):511-518. doi: 10.1016/j.jhep.2017.11.017. Epub 2017 Nov 21.
4
Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis.联合应用肝脏疾病评分系统的数据可更好地预测酒精性肝炎患者的预后。
Gastroenterology. 2015 Aug;149(2):398-406.e8; quiz e16-7. doi: 10.1053/j.gastro.2015.04.044. Epub 2015 Apr 29.
5
Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort.酒精性肝炎短期死亡率的九种评分模型:在经活检证实的队列中的交叉验证
Aliment Pharmacol Ther. 2014 Apr;39(7):721-32. doi: 10.1111/apt.12654.
6
Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis.评估急性-on-慢性肝衰竭评分系统对酒精性肝炎患者短期死亡率的预测价值。
World J Gastroenterol. 2016 Nov 7;22(41):9205-9213. doi: 10.3748/wjg.v22.i41.9205.
7
Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score.酒精性肝炎死亡率预测因素分析及格拉斯哥酒精性肝炎评分的推导与验证。
Gut. 2005 Aug;54(8):1174-9. doi: 10.1136/gut.2004.050781.
8
The management of alcoholic hepatitis: a prospective comparison of scoring systems.酒精性肝炎的治疗:评分系统的前瞻性比较。
Aliment Pharmacol Ther. 2013 Sep;38(6):603-10. doi: 10.1111/apt.12414. Epub 2013 Jul 23.
9
Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation.不同肝病评分系统预测经颈静脉肝内门体分流术创建后早期死亡率的预后能力。
J Vasc Interv Radiol. 2013 Mar;24(3):411-20, 420.e1-4; quiz 421. doi: 10.1016/j.jvir.2012.10.026. Epub 2013 Jan 9.
10
MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis.对于酒精性肝炎患者,终末期肝病模型(MELD)评分是比Child-Turcotte-Pugh评分或判别函数评分更好的预后模型。
J Hepatol. 2005 May;42(5):700-6. doi: 10.1016/j.jhep.2004.12.022.

引用本文的文献

1
Alcohol-Associated Hepatitis: Short- and Long-Term Management.酒精性肝炎:短期和长期管理
Dig Dis Sci. 2025 Jan;70(1):74-84. doi: 10.1007/s10620-024-08705-1. Epub 2024 Nov 22.
2
Advances in the management of alcohol-associated liver disease.酒精性肝病管理的进展
Gastroenterol Rep (Oxf). 2024 Nov 5;12:goae097. doi: 10.1093/gastro/goae097. eCollection 2024.
3
An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study.人工智能生成的模型预测酒精性肝炎的 90 天生存率:一项全球队列研究。
Hepatology. 2024 Nov 1;80(5):1196-1211. doi: 10.1097/HEP.0000000000000883. Epub 2024 Apr 12.
4
Bacteremia in Alcoholic Hepatitis.酒精性肝炎中的菌血症
Case Reports Hepatol. 2021 Oct 13;2021:9947213. doi: 10.1155/2021/9947213. eCollection 2021.
5
Moderate Alcoholic Hepatitis.中度酒精性肝炎。
Clin Liver Dis. 2021 Aug;25(3):537-555. doi: 10.1016/j.cld.2021.03.001. Epub 2021 May 27.
6
Comparison of prognostic scores for alcoholic hepatitis: a retrospective study.酒精性肝炎预后评分的比较:一项回顾性研究。
Croat Med J. 2021 Feb 28;62(1):17-24. doi: 10.3325/cmj.2021.62.17.
7
Trajectory of Serum Bilirubin Predicts Spontaneous Recovery in a Real-World Cohort of Patients With Alcoholic Hepatitis.血清胆红素轨迹可预测酒精性肝炎真实世界队列患者的自发恢复。
Clin Gastroenterol Hepatol. 2022 Feb;20(2):e289-e297. doi: 10.1016/j.cgh.2021.01.042. Epub 2021 Jan 28.
8
Alcoholic hepatitis: Diagnosis and prognosis.酒精性肝炎:诊断与预后
Clin Liver Dis (Hoboken). 2013 Apr 24;2(2):80-83. doi: 10.1002/cld.164. eCollection 2013 Apr.
9
Predictors of 90-day mortality in patients with severe alcoholic hepatitis: Experience with 183 patients at a tertiary care center from India.重症酒精性肝炎患者90天死亡率的预测因素:来自印度一家三级医疗中心183例患者的经验
Indian J Gastroenterol. 2018 Mar;37(2):141-152. doi: 10.1007/s12664-018-0842-0. Epub 2018 Apr 28.
10
Pathophysiology and Management of Alcoholic Liver Disease: Update 2016.酒精性肝病的病理生理学与管理:2016年更新
Gut Liver. 2017 Mar 15;11(2):173-188. doi: 10.5009/gnl16477.